BIOMX INC. WARRANT TO PURCHASE COMMON STOCKSecurity Agreement • February 27th, 2025 • BiomX Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 27th, 2025 Company Industry JurisdictionBiomX Inc., a company incorporated under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Requisite Stockholder Approval Date (the “Initial Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), the number set forth above next to “Warrant Shares” of fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, th
BIOMX INC. AMENDED AND RESTATED WARRANT TO PURCHASE COMMON STOCKSecurity Agreement • February 27th, 2025 • BiomX Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 27th, 2025 Company IndustryBiomX Inc., a company incorporated under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Amendment Date and until this Warrant is exercised in full (the “Expiration Date”), the number set forth above next to “Warrant Shares” of fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Amended and Restated Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), shall have the meanings set forth in
BIOMX INC. WARRANT TO PURCHASE COMMON STOCKSecurity Agreement • February 27th, 2025 • BiomX Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 27th, 2025 Company IndustryBiomX Inc., a company incorporated under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Requisite Stockholder Approval Date (the “Initial Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), the number set forth above next to “Warrant Shares” of fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”) Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, thi
BIOMX INC. PRE-FUNDED WARRANT TO PURCHASE COMMON STOCKSecurity Agreement • February 27th, 2025 • BiomX Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 27th, 2025 Company IndustryBiomX Inc., a company incorporated under the laws of Delaware (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [HOLDER], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Requisite Stockholder Approval Date (the “Initial Exercisability Date”) and until this Warrant is exercised in full (the “Expiration Date”), the number set forth above next to “Warrant Shares” of fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the “Warrant Shares”) Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this “Warrant”), sh